RecallDepth
Class III Terminated

BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 100 mg, packaged in a) 60-count bottles (NDC 59746-315-60) and b) 100-count bottles (NDC 59746-315-01), Rx only, Manufactured by: Julibant Life Sciences Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA.

This recall has been terminated (originally issued April 19, 2017).

Company
Jubilant Cadista Pharmaceuticals, Inc.
Recall Initiated
April 8, 2016
Posted
April 19, 2017
Recall Number
D-0669-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
20,882 bottles
Firm Location
Salisbury, MD, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #s: a) BU15001B, BU15003D, Exp 12/16; b) BU15002A, Exp 12/16

More recalls by Jubilant Cadista Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class III Drug recalls